These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17174303)

  • 1. Melatonin in the eye: implications for glaucoma.
    Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP; Rosenstein RE
    Exp Eye Res; 2007 Jun; 84(6):1021-30. PubMed ID: 17174303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis.
    Rosenstein RE; Pandi-Perumal SR; Srinivasan V; Spence DW; Brown GM; Cardinali DP
    J Pineal Res; 2010 Aug; 49(1):1-13. PubMed ID: 20492443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of melatonin in the eye and ocular dysfunctions.
    Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP
    Vis Neurosci; 2006; 23(6):853-62. PubMed ID: 17266777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of melatonin in experimental free radical-related ocular diseases.
    Siu AW; Maldonado M; Sanchez-Hidalgo M; Tan DX; Reiter RJ
    J Pineal Res; 2006 Mar; 40(2):101-9. PubMed ID: 16441546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin: a novel neuroprotectant for the treatment of glaucoma.
    Belforte NA; Moreno MC; de Zavalía N; Sande PH; Chianelli MS; Keller Sarmiento MI; Rosenstein RE
    J Pineal Res; 2010 May; 48(4):353-64. PubMed ID: 20374442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues.
    Wiechmann AF; Summers JA
    Prog Retin Eye Res; 2008 Mar; 27(2):137-60. PubMed ID: 18316227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential.
    Agorastos A; Huber CG
    J Pineal Res; 2011 Jan; 50(1):1-7. PubMed ID: 21073517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin: new places in therapy.
    Maharaj DS; Glass BD; Daya S
    Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential.
    Crooke A; Huete-Toral F; Martínez-Águila A; Colligris B; Pintor J
    Expert Opin Drug Discov; 2012 Oct; 7(10):989-1001. PubMed ID: 22860991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential value of natural antioxidative treatment in glaucoma.
    Mozaffarieh M; Grieshaber MC; Orgül S; Flammer J
    Surv Ophthalmol; 2008; 53(5):479-505. PubMed ID: 18929760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of melatonergic drugs in analgesia: mechanisms of action.
    Srinivasan V; Pandi-Perumal SR; Spence DW; Moscovitch A; Trakht I; Brown GM; Cardinali DP
    Brain Res Bull; 2010 Mar; 81(4-5):362-71. PubMed ID: 20005925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in relation to surgery: is there a role for the antioxidant melatonin?
    Kücükakin B; Gögenur I; Reiter RJ; Rosenberg J
    J Surg Res; 2009 Apr; 152(2):338-47. PubMed ID: 18262562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin as pharmacologic support in burn patients: a proposed solution to thermal injury-related lymphocytopenia and oxidative damage.
    Maldonado MD; Murillo-Cabezas F; Calvo JR; Lardone PJ; Tan DX; Guerrero JM; Reiter RJ
    Crit Care Med; 2007 Apr; 35(4):1177-85. PubMed ID: 17312564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma.
    Martínez-Águila A; Martín-Gil A; Carpena-Torres C; Pastrana C; Carracedo G
    Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33668357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and glaucoma: injury in the anterior segment of the eye.
    Saccà SC; Izzotti A
    Prog Brain Res; 2008; 173():385-407. PubMed ID: 18929123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological consequences of oxidative stress in ocular tissues.
    Ohia SE; Opere CA; Leday AM
    Mutat Res; 2005 Nov; 579(1-2):22-36. PubMed ID: 16055157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin receptors in brain areas and ocular tissues of the teleost Tinca tinca: characterization and effect of temperature.
    López Patiño MA; Alonso-Gómez AL; Guijarro A; Isorna E; Delgado MJ
    Gen Comp Endocrinol; 2008 Feb; 155(3):847-56. PubMed ID: 18177872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin: Nature's most versatile biological signal?
    Pandi-Perumal SR; Srinivasan V; Maestroni GJ; Cardinali DP; Poeggeler B; Hardeland R
    FEBS J; 2006 Jul; 273(13):2813-38. PubMed ID: 16817850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).
    Konturek SJ; Konturek PC; Brzozowska I; Pawlik M; Sliwowski Z; Cześnikiewicz-Guzik M; Kwiecień S; Brzozowski T; Bubenik GA; Pawlik WW
    J Physiol Pharmacol; 2007 Sep; 58(3):381-405. PubMed ID: 17928638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin, the pineal gland and their implications for headache disorders.
    Peres MF
    Cephalalgia; 2005 Jun; 25(6):403-11. PubMed ID: 15910564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.